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Introduction
Ovarian tumors are common diseases of the female
genital tract. Epithelial ovarian cancers account for the
majority of female ovarian neoplasms. In the USA, the
incidence of ovarian cancer is 14.5–18.1/100,000 in the
general population [1]. There is a higher incidence in
white women (19.8/100,000) but a lower incidence in
black women (9.0/100,000) [2]. Epithelial ovarian
cancers usually originate from single colonies. Tumors
composed of a mixture of endocervical-type (Mullerian)
mucinous cells, serous cells, endometrioid cells,
squamous cells, and undifferentiated cells are classified
as “seromucinous” tumors as they exhibit both serous
and mucinous features. We report a patient who
presented with an ovarian seromucinous tumor.
Case Report
A 27-year-old female, gravida 2, para 2, abortus 0, with
no significant prior medical history presented with a
palpable abdominal mass and abdominal disten-
sion. There was no abdominal pain, abnormal vaginal
discharge, or bowel habit change. Physical and pelvic
examinations revealed a palpable mass with mild
tenderness in the pelvoabdominal region. The uterus
and cervix were normal. Gynecologic ultrasonography
and pelvoabdominal computed tomography revealed
a huge multilocular cyst measuring 22 = 17 cm on the
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right side of the pelvis (Figure 1). A focal solid part was
also noted. The other pelvic and abdominal organs
appeared normal on gross inspection. There were no
obvious lymphadenopathies or ascites. The serum
CA-125 level was initially 114 U/mL. During staging
surgery, a tumor about the same size was found on the
right ovary. The outer surface was smooth. The tumor
was filled with clear fluid and had multiple septum
formation. Papillary growth was noted on the inner
surface. Approximately 200 mL of ascites was drained
from the intraperitoneal cavity. Some papillary growth
was noted in the pelvic peritoneum. Pathological
sections of the right ovarian tumor revealed a mixture
of endocervical-type mucinous, serous, endometrioid,
squamous, and undifferentiated cells (Figure 2). These
neoplastic cells were located mainly within the ovarian
epithelium with only focal stromal invasion (Figure 3).
The left ovary was normal. Metastatic implants were
found in the pelvic peritoneum. Malignant cells were
seen in the ascites. The surgical stage of the tumor was
IIC. The patient received six courses of chemotherapy
with a combination of carboplatin and paclitaxel. Since
the operation, she has been regularly followed at our
hospital. The CA-125 level was within the normal range
until the time of writing.
Discussion
The term “seromucinous ovarian tumor” was proposed
by Shappell et al to classify endocervical mucinous
tumors that have similar morphologic and behavior
patterns to serous tumors [3]. In 1963, the International
Federation of Gynecology and Obstetrics (FIGO)
accepted an intermediate group of ovarian carcinomas
of low malignant potential. In 1973, the World Health
Organization (WHO) adopted the term “borderline
malignancies” to describe these tumors. Borderline
tumors represent approximately 10–15% of all epithe-
lial ovarian malignancies. There are discrepancies in
the reported incidence of ovarian borderline malignan-
cies [2,4].
Borderline mucinous cystic tumors are characterized
by obvious and extensive intestinalization of their
epithelial lining. A minority of these tumors (5% in a
tumor registry series) lack obvious intestinal epi-
thelium. The cells resemble endocervical gland cells
morphologically; therefore, they have been designated
“endocervical-like” cells or “of Mullerian type”. Micro-
scopically, they do not contain the goblet or Paneth
cells seen in intestinal epithelium. Papillary architec-
Figure 1. Right pelvic multilocular cystic mass extends to the
abdominal cavity. No enlarged lymph nodes are evident in the
retroperitoneal area, para-aortic area, and inguinal regions.
Figure 2. Histopathologic features of the right ovarian tumor:
it is composed of a mixture of endocervical-type mucinous,
serous, endometrioid, squamous, and undifferentiated cells.
(A) Papillary epithelium of mixed cell types (hematoxylin &
eosin, = 40); (B) endocervical mucinous-type cell (hematoxylin
& eosin, = 100); (C) serous type cell (hematoxylin & eosin, =
200); (D) endometrioid type cell (hematoxylin & eosin, = 400).
Figure 3. (A) Atypical proliferating tumor in most of the
ovarian epithelium in the main tumor (hematoxylin & eosin, =
200); (B) focal stromal invasion (arrow) less than 5 mm in
depth (microinvasion) (hematoxylin & eosin, = 40); (C) con-
fluent micropapillary structure more than 5 mm in diameter
(hematoxylin & eosin, = 40); (D) invasive peritoneal implants
with lymphovascular space invasion (double arrow) (hema-
toxylin & eosin, = 400).
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ture is also found in these tumors, in contrast to
intestinal-type mucinous tumors, which are usually
multilocular, glandular, and cystic [3].
Seromucinous ovarian tumors are composed of either
pure endocervical-type cells or a mixture of endocervical-
type mucinous, serous, endometrioid, squamous, and
undifferentiated cells with abundant eosinophilic
cytoplasm. They used to be termed “mixed epithelial
papillary cystadenoma of borderline malignancy of
Mullerian type”. Because the tumors lack stromal
invasion, they were initially termed “Mullerian mucinous
or endocervical-type papillary cystadenoma of border-
line malignancy”. They are reported to be primarily
limited to borderline and microinvasive tumors. Tumor-
related death has rarely been reported.
Atypical proliferative tumors, intraepithelial, micro-
invasive, and invasive carcinomas are classified according
to their pathologic characteristics [3]. The presence of
either intraepithelial carcinoma or microinvasion has
no adverse effect on behavior. Shappell et al found that
marked cytologic atypia, tumor necrosis, and mitotic
index have no independent adverse impact on survival.
All noninvasive tumors as well as those with micro-
invasion (< 5 mm) behave in a benign fashion. Micro-
papillary structure is related to tumor recurrence and
death in advanced-stage diseases [3]. The same is true
for serous ovarian tumors. Our patient had stage IIC
disease. Micropapillary structures and microinvasion
were both noted on pathology (Figure 3). The patient
has been disease-free for 2 years at the time of writing.
DNA cytophotometry has revealed that aneuploidy
is an indicator of the aggressiveness of tumors [5,6].
DNA aneuploidy also indicates a high risk of recurrence
[2]. Most borderline tumors are diploid and have good
prognosis. Studies of other molecular markers have not
uncovered a reliable predictor of tumor behavior. Studies
involving the clinical course, prognostic analysis, and
optimal therapy for this interesting group of tumors
are needed. Accurate diagnosis and clinical staging
lead to better treatment results, and reduce the use of
unnecessary aggressive therapies.
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